The Heart Outcomes Prevention Evaluation (HOPE) Study
Investigators
Effects of an angiotensin-converting enzyme inhibitor ramipril,
on cardiovascular events in high risk patients
N Engl J Med
(Jan) 342:145-153, 2000

The abstract of this paper is available from the NEJM:
Click here.
An accompanying editorial is available from the NEJM:
Click here.